Researching a Cure 2012
For over a decade, researchers and scientists have been relying on the ALS Therapy Alliance's expertise and funding to advance their studies of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease.
The ALS Therapy Alliance's research program is overseen by the group's board of award-winning researchers and scientists, as well as corporate executives and individuals who strive to learn more about the neurodegenerative disease, its cause and possible cure.
The organization has raised nearly $28 million over the past 10 years thanks to its partnership with CVS/pharmacy.
The ALS Therapy Alliance is designated by the IRS as a not-for-profit 501 (c) (3) organization.
Points of Interest
History & Mission
The ALS Therapy Alliance (ATA) was established in 2000 to facilitate ALS research projects and collaborations among a diverse group of scientists and clinicians at multiple institutions to cure ALS. This represents a unique collaborative enterprise that spans multiple laboratories, universities and disciplines.
Directors & Staff
The ALS Therapy Alliance is fortunate to have a Board of Directors comprised of talented clinicians, scientists and business associates who are committed to the organization’s mission.
Current Projects
Ongoing research is being conducted in the fight against amyotrophic lateral sclerosis (ALS) by our team of clinicians, doctors and scientists at top hospitals and universities.
How Can I Help?
There are many ways you can help support the research being conducted by the ALS Therapy Alliance to find a cure for amyotrophic lateral sclerosis (ALS), otherwise known as Lou Gehrig's disease.
0 comment(s)